Our client was seeking NICE approval for their ultra-orphan drug in an indication that was not well ...
Read moreIdentification of current cost of oncology care treatment options.
Read moreDevelopment of local market access plans that could be used by EU affiliates, who had not previously...
Read moreOur client needed to understand the clinical and economic evidence requirements that drive payer dec...
Read moreOur client was seeking market authorisation for one indication and were expected a secondary indicat...
Read moreDevelopment of a pricing strategy and submission of pricing and reimbursement dossiers for country-s...
Read moreCompany had minimal pricing governance process in place which was leading to sub-optimal pricing in ...
Read moreThe client required expert operational pricing support and insights during a company restructure whi...
Read moreOur client had in-licenced a hospital drug that they were seeking to launch in the EU, following a r...
Read moreOur client was struggling to understand the value of their product (a single-use treatment for an ul...
Read more